Funding
← Back to your selection

Qumra Capital

Activity from announced rounds

Activity in this selectionOct 24, 2026 · Enterprise software · Jul 27, 2026

Qumra Capital is the investment firm identified by Remepy and in Buildots’ issuer financing announcement.

Recorded funding activity

Buildots measures construction progress from site imagery. Remepy combines medicines with therapeutic applications, while QuantHealth simulates trials before enrollment. The recorded activity does not assign a particular unnamed fund.

Sources
Rounds participated in
3
Confirmed lead rounds
0
2 roles undisclosed
New companies
3
First participation on record · 0 follow-on
Funding in participating rounds
$300M
3 disclosed · full round size, not this investor’s share

By stage

Series B1
Series C+1
Undisclosed1

By primary sector

Biotech1
Cybersecurity1
Proptech1

By country

Israel2
United States1

Rounds

3 in this selection
Buildots

Construction intelligence software turns site captures into verified progress tracking and early schedule-risk warnings.

$130MFunding
Participant
QuantHealth

AI-driven platform that simulates clinical trials to predict outcomes before patient enrollment

$45MSeries B
Role not disclosed
Zenity

AI security and governance platform purpose-built for enterprise AI agents

$125MSeries C
Role not disclosed